MN1 proto-oncogene (MN1) (C-Term) Peptid
MN1
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle Meningioma 1 (MN1) Produkte
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
- Protein Region
- C-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- EKAKPQNPNS KEAHDLPANK ASASQPGSHL QCLSVHCTDD VGDAKARASV
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-MN1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
- Hintergrund
-
Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4,22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis.
Alias Symbols: MGCR, MGCR1, MGCR1-PEN, dJ353E16.2
Protein Interaction Partner: EP300
Protein Size: 1320 - Molekulargewicht
- 136 kDa
- Gen-ID
- 4330
- NCBI Accession
- NM_002430, NP_002421
- UniProt
- Q10571
-
Sie sind hier:
